Suppr超能文献

酒精性肝硬化中的高纤溶状态:1型纤溶酶原激活物抑制物相对缺乏

Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.

作者信息

Ferguson James W, Helmy Ahmed, Ludlam Christopher, Webb David J, Hayes Peter C, Newby David C

机构信息

Department of Hepatology, University of Edinburgh, Royal Infirmary of Edinburgh, 51 Little France Crescent, Edinburgh, EH16 4SU, UK.

出版信息

Thromb Res. 2008;121(5):675-80. doi: 10.1016/j.thromres.2007.07.008. Epub 2007 Sep 17.

Abstract

BACKGROUND

Over activity of the fibrinolytic system (hyperfibrinolysis) occurs in cirrhosis and has been shown to correlate with the risk of variceal hemorrhage. We have developed a model for assessing acute tissue plasminogen activator (t-PA) release in vivo in man. The aims of the study were to assess the contribution of basal and stimulated t-PA release to hyperfibrinolysis in patients with alcoholic cirrhosis.

METHODS

Bilateral forearm blood flow and plasma fibrinolytic variables were measured in 8 patients with biopsy proven alcohol induced cirrhosis, ascites and portal hypertension, and 8 age and sex matched healthy controls during infusion of bradykinin (100-900 pmol/min; endothelium-dependent vasodilator that releases t-PA) followed by sodium nitroprusside (SNP 2-8 microg/min; a control endothelium-independent vasodilator).

RESULTS

Baseline plasma t-PA antigen concentrations were higher in patients (14+/-2 vs 9+/-1 ng/mL; p<0.05) whereas plasma plasminogen activator inhibitor type-1 (PAI-1) antigen concentrations were similar (59+/-16 vs 55+/-11 ng/mL; p=NS). This resulted in an increased t-PA activity (3+/-1 vs 0+/-0 IU/mL; p<0.05) and reduced PAI-1 activity (9+/-2 vs 21+/-2 AU/mL; p<0.05) indicating a relative deficiency of PAI-1 in patients with cirrhosis. Bradykinin and SNP caused dose-dependent vasodilatation (p<0.001 for both) that did not differ between the two groups. Bradykinin caused a similar release of t-PA antigen (p<0.05 for both) in both patients and controls (24+/-17 vs 23+/-7 ng/100 mL/min; p=ns) without affecting PAI-1 concentrations. Local t-PA activity was increased in patients following acute stimulated t-PA release (5+/-1 vs 3+/-1 IU/mL; p<0.05). SNP caused no significant change in fibrinolytic parameters.

CONCLUSION

Patients with alcoholic cirrhosis have a higher basal plasma t-PA activity because of a failure to increase plasma concentrations of its inhibitor, PAI-1. Furthermore, despite releasing normal amounts of t-PA acutely, higher t-PA activity remained due to the relative deficiency of PAI-1. This suggests that the pathogenesis of hyperfibrinolysis in alcoholic cirrhosis is the result of a relative PAI-1 deficiency and enhanced basal t-PA release.

摘要

背景

纤维蛋白溶解系统活性过高(高纤维蛋白溶解)在肝硬化中出现,并且已被证明与静脉曲张出血风险相关。我们已经开发出一种用于评估人体体内急性组织型纤溶酶原激活物(t-PA)释放的模型。本研究的目的是评估基础和刺激后的t-PA释放在酒精性肝硬化患者高纤维蛋白溶解中的作用。

方法

在8例经活检证实为酒精性肝硬化、腹水和门静脉高压的患者以及8例年龄和性别匹配的健康对照者中,在输注缓激肽(100 - 900 pmol/分钟;可释放t-PA的内皮依赖性血管扩张剂)后接着输注硝普钠(SNP 2 - 8微克/分钟;一种对照性的非内皮依赖性血管扩张剂)期间,测量双侧前臂血流量和血浆纤维蛋白溶解变量。

结果

患者的基线血浆t-PA抗原浓度较高(14±2对9±1纳克/毫升;p<0.05),而血浆纤溶酶原激活物抑制剂1型(PAI-1)抗原浓度相似(59±16对55±11纳克/毫升;p=无显著性差异)。这导致t-PA活性增加(3±1对0±0国际单位/毫升;p<0.05)以及PAI-1活性降低(9±2对21±2任意单位/毫升;p<0.05),表明肝硬化患者中PAI-1相对缺乏。缓激肽和SNP引起剂量依赖性血管扩张(两者p<0.001),两组之间无差异。缓激肽在患者和对照者中引起相似的t-PA抗原释放(两者p<0.05)(24±17对23±7纳克/100毫升/分钟;p=无显著性差异),且不影响PAI-1浓度。急性刺激t-PA释放后患者的局部t-PA活性增加(5±1对3±1国际单位/毫升;p<0.05)。SNP未引起纤维蛋白溶解参数的显著变化。

结论

酒精性肝硬化患者基础血浆t-PA活性较高,原因是其抑制剂PAI-1的血浆浓度未能升高。此外,尽管急性释放的t-PA量正常,但由于PAI-1相对缺乏,t-PA活性仍然较高。这表明酒精性肝硬化中高纤维蛋白溶解的发病机制是PAI-1相对缺乏和基础t-PA释放增强的结果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验